Healthcare use is elevated two decades before a first demyelinating event and differs by age and sex
Annals of Clinical and Translational Neurology · 2025-02 · 12 (2) · 415-432
DOI: 10.1002/acn3.52267 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 29.01.2025. Verfasst von Helen Tremlett und 10 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine (Neurology), and the Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, British Columbia, Can…. Hauptthemen laut MEDLINE: Patient Acceptance of Health Care, Multiple Sclerosis. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Multiple Sclerosis Society, Multiple Sclerosis Society of Canada.
Abstract (Originalsprache)
Objective
Elevated healthcare use before multiple sclerosis (MS) onset suggests earlier opportunity to identify MS. Yet their timing and sociodemographic effects are unclear. We examined rates of healthcare use (and by age/sex) for >two decades pre‐MS onset.
Methods
We identified people with MS (PwMS) using administrative data from Canada (Ontario) and Sweden (1991–2020) (“administrative” cohort), and the Swedish MS Registry (“clinical” cohort). The first MS/demyelinating diagnostic code (administrative) or symptom onset (clinical) defined MS onset. We compared annual rates of healthcare use (hospital, physician, and emergency‐room [ED]) pre‐onset between PwMS and up to five matched population controls using negative binomial regression, and by age/sex.
Results
The administrative cohort = 35,018/136,007 PwMS/controls (Ontario), and 10,269/51,297 (Sweden). Rates of healthcare use were higher for PwMS than controls up to 28 (of 29) years (Ontario) and up to 15 (of 19) years (Sweden) pre‐onset. Annual healthcare use rose steadily as onset approached, particularly escalating 7 years pre‐onset in Ontario (e.g., hospital visit rate ratios [RRs] exceeded 1.30), and 6 years in Sweden (physician visit RRs > 1.10). RRs peaked the year pre‐onset (ED visits [Ontario] = 3.04; 95% CI: 2.94–3.13, physician visits [Sweden] = 2.51; 95% CI: 2.44–2.59). In the year pre‐onset, RRs were disproportionately higher for males (ED RRs [Ontario] = 3.30; 95% CI: 3.13–3.48 vs. females = 2.90; 95% CI: 2.79–3.02), and dropped steadily by age (physician visit RRs [Sweden] = 2.61/2.27/1.97/1.72 for 50/40/30/20‐year‐olds). The smaller clinical cohort (7604/37,974 PwMS/controls) exhibited similar patterns, albeit more modest, with RRs elevated up to 5 years pre‐onset (physician visit RR [year‐5] = 1.08; 95% CI: 1.02–1.14; RR [year‐1] = 1.39;1.33–1.46).
Interpretation
Higher healthcare use was evident decades before MS onset, escalating 6–7 years pre‐onset, peaking the year before, being disproportionately higher for males and older PwMS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Faculty of Medicine (Neurology), and the Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, British Columbia, Canada.
- ICES, Toronto, Ontario, Canada.
- Department of Clinical Neuroscience, Karolinska Institutet, Department of Neurology, Karolinska University Hospital, Stockholm, Sweden.
- Schools of Pharmacy and Public Health Sciences, University of Waterloo, Waterloo, Ontario, Canada.
- Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
- Department of Community Health Sciences, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
ORCID-Profile: Helen Tremlett, Ali Manouchehrinia, Kyla A McKay
Förderung
- National Multiple Sclerosis Society
- Multiple Sclerosis Society of Canada
Zitieren
APA
Tremlett, H., Zhu, F., Everett, K., Asaf, A., Manouchehrinia, A., Li, P., McKay, K. A., Hillert, J., Zhao, Y., Maxwell, C., & Marrie, R. A. (2025). Healthcare use is elevated two decades before a first demyelinating event and differs by age and sex. Annals of Clinical and Translational Neurology, 12(2), 415-432. https://doi.org/10.1002/acn3.52267
Vancouver
Tremlett H, Zhu F, Everett K, Asaf A, Manouchehrinia A, Li P, et al. Healthcare use is elevated two decades before a first demyelinating event and differs by age and sex. Annals of Clinical and Translational Neurology. 2025;12(2):415-432. doi:10.1002/acn3.52267
BibTeX
@article{Tremlett2025,
author = {Tremlett, Helen and Zhu, Feng and Everett, Karl and Asaf, Ayesha and Manouchehrinia, Ali and Li, Ping and McKay, Kyla A and Hillert, Jan and Zhao, Yinshan and Maxwell, Colleen and Marrie, Ruth Ann},
title = {Healthcare use is elevated two decades before a first demyelinating event and differs by age and sex},
journal = {Annals of Clinical and Translational Neurology},
year = {2025},
volume = {12},
number = {2},
pages = {415--432},
doi = {10.1002/acn3.52267}
}
EUVIMED